Maria del Carmen Gonzalez Montelongo

Dr. Maria del Carmen Gonzalez Montelongo

Biomedical Research and Innovation Institute of Cadiz, Cádiz, Andalusia, Spain
orcid
Interim Substitute Teacher at UCA (Cadiz-Spain), email: mari...

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2014 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
VCVerónica Casañas‐Sánchez
Verónica Casañas‐Sánchez
JPJosé Antonio Pérez Pérez
José Antonio Pérez Pérez
NFNoemí Fabelo
Noemí Fabelo
Antonio V. Herrera-HerreraAntonio V. Herrera-Herrera
Antonio V. Herrera-Herrera
CFCecilia Fernández
Cecilia Fernández
Mario DiazMario Diaz
Mario Diaz

27 November 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
BCBelén Cuevas
Belén Cuevas
AAAna Isabel Arroba
Ana Isabel Arroba
CRCarolina De los Reyes
Carolina De los Reyes
MJMaría Laura Gómez Jaramillo
María Laura Gómez Jaramillo
Maria del Carmen Gonzalez MontelongoMaria del Carmen Gonzalez Montelongo
Maria del Carmen Gonzalez Montelongo
EZEva Zubía
Eva Zubía
Brown algae of the Family Dictyotaceae produce an array of structurally diverse terpenoids, whose biomedical potential in the anti-inflammatory area has been scarcely explored. Herein, the chemical study of the alga Rugulopteryx okamurae has led to the isolation of ten new diterpenoids: rugukadiol A (1), rugukamurals A–C (2–4), and ruguloptones A–F (6–10). The structures of the new compounds were established by spectroscopic means. Compound 1 exhibits an unprecedented diterpenoid skeleton featuring a bridged tricyclic undecane system. Compounds 2–10 belong to the secospatane class of diterpenoids and differ by the oxygenated functions that they contain. In anti-inflammatory assays, the new diterpenoid 1 and the secospatanes 5 and 10 significantly inhibited the production of the inflammatory mediator NO in LPS-stimulated microglial cells Bv.2 and macrophage cells RAW 264.7. Moreover, compounds 1 and 5 were found to strongly inhibit the expression of Nos2 and the pro-inflammatory cytokine Il1b in both immune cell lines.

1 May 2010 in Molecular Endocrinology
Verified
Journal Article
Closed access
Maria del Carmen Gonzalez MontelongoMaria del Carmen Gonzalez Montelongo
Maria del Carmen Gonzalez Montelongo
Raquel MarinRaquel Marin
Raquel Marin
TGTomás Gómez
Tomás Gómez
JMJorge Marrero-Alonso
Jorge Marrero-Alonso
Mario DiazMario Diaz
Mario Diaz
We show that androgens, testosterone and 5alpha-dihydrotestosterone (DHT), acutely (approximately 40 min) provoke the mechanical potentiation of spontaneous and agonist-induced contractile activity in mouse colonic longitudinal smooth muscle. The results using flutamide, finasteride, cycloheximide, and actinomycin D indicate that androgen-induced potentiation is dependent on androgen receptors, requires reduction of testosterone to DHT, and occurs independently of transcriptional and translational events. Using permeabilized colonic smooth muscle preparations, we could demonstrate that mechanical potentiation is entirely due to calcium sensitization of contractile machinery. In addition, DHT (10 nm) increased phosphorylation of both 20-kDa myosin light chain (LC(20)) [regulatory myosin light chain, (MLC)] and CPI-17 (an endogenous inhibitor of MLC phosphatase). Paralleling these findings, inhibition of Rho-associated Rho kinase (ROK) and/or protein kinase C (PKC) with, respectively, Y27632 and chelerythrine, prevented LC(20) phosphorylation and abolished calcium sensitization. In addition, inhibition of ROK prevents CPI-17 phosphorylation, indicating that ROK is located upstream PKC-mediated CPI-17 modulation in the signalling cascade. Additionally, androgens induce a rapid activation of RhoA and its translocation to the plasma membrane to activate ROK. The results demonstrate that androgens induce sensitization of colonic smooth muscle to calcium through activation of ROK, which in turn, activates PKC to induce CPI-17 phosphorylation. Activation of this pathway induces a potent steady stimulation of LC(20) by inhibiting MLC phosphatase and displacing the equilibrium of the regulatory subunit towards its phosphorylated state. This is the first demonstration that colonic smooth muscle is a physiological target for androgen hormones, and that androgens modulate force generation of smooth muscle contractile machinery through nongenomic calcium sensitization pathways.

Verified
Journal Article
Open access
PDF file
MJM Laura Gómez Jaramillo
M Laura Gómez Jaramillo
FCFátima Cano Cano
Fátima Cano Cano
Maria del Carmen Gonzalez MontelongoMaria del Carmen Gonzalez Montelongo
Maria del Carmen Gonzalez Montelongo
ACAntonio Campos-Caro
Antonio Campos-Caro
MDManuel Aguilar Diosdado
Manuel Aguilar Diosdado
AAAna Isabel Arroba
Ana Isabel Arroba
Huntington’s disease (HD) is a neurodegenerative disorder caused by a toxic, aggregation-prone expansion of CAG repeats in the HTT gene with an age-dependent progression that leads to behavioral, cognitive and motor symptoms. Principally affecting the frontal cortex and the striatum, mHTT disrupts many cellular functions. In fact, increasing evidence shows that peripheral tissues are affected by neurodegenerative diseases. It establishes an active crosstalk between peripheral tissues and the brain in different neurodegenerative diseases. This review focuses on the current knowledge of peripheral tissue effects in HD animal and cell experimental models and identifies biomarkers and mechanisms involved or affected in the progression of the disease as new therapeutic or early diagnostic options. The particular changes in serum/plasma, blood cells such as lymphocytes, immune blood cells, the pancreas, the heart, the retina, the liver, the kidney and pericytes as a part of the blood–brain barrier are described. It is important to note that several changes in different mouse models of HD present differences between them and between the different ages analyzed. The understanding of the impact of peripheral organ inflammation in HD may open new avenues for the development of novel therapeutic targets.

1 August 2010 in Steroids
Verified
Journal Article
Closed access
Maria del Carmen Gonzalez MontelongoMaria del Carmen Gonzalez Montelongo
Maria del Carmen Gonzalez Montelongo
Raquel MarinRaquel Marin
Raquel Marin
TGTomás Gómez
Tomás Gómez
Mario DiazMario Diaz
Mario Diaz

1 December 2006 in Endocrinology
Verified
Journal Article
Closed access
Maria del Carmen Gonzalez MontelongoMaria del Carmen Gonzalez Montelongo
Maria del Carmen Gonzalez Montelongo
Raquel MarinRaquel Marin
Raquel Marin
TGTomás GómEz
Tomás GómEz
Mario DiazMario Diaz
Mario Diaz
We demonstrate that testosterone and its active metabolite 5α-dihydrotestosterone acutely (∼30 min) potentiate mouse ileal, but not duodenal, muscle activity. Androgens augment the amplitude of spontaneous peak-to-peak oscillations, alter the spontaneous activity frequency spectrum, and increase the amplitude of calcium-induced and carbachol-induced contractions. Concentration-dependence analyses revealed that maximal potentiation (449–910%) occurred at physiological concentrations of androgens (100 pm to 10 nm) with EC50 values in the picomolar range (8–20 pm). Western blot analyses using an antiandrogen receptor (anti-AR) antibody revealed the presence of two different AR proteins migrating at 87 and 110 kDa in ileal, but not duodenal, extracts. Androgen-induced potentiation was prevented by preincubation with AR antagonists flutamide or cyproterone acetate but was unaffected by pretreatment with cycloheximide plus actinomycin D, indicating that potentiation was mediated by ARs via a novel nongenomic mechanism. Androgen effects were mimicked by polyamines putrescine and spermine and were blocked by the ornithine decarboxylase and S-adenosyl-l-methionine decarboxylase inhibitors α-difluoromethylornithine and berenil, respectively. Accordingly, androgens increase α-difluoromethylornithine-sensitive ornithine-decarboxylase- mediated l-ornithine decarboxylation in ileal tissues within the same time course as isometric potentiation. Both putrescine and dihydrotestosterone induced Ca2+ sensitization of ionomycin-permeabilized ileal smooth muscle. Finally, inhibition of the Rho kinase (ROK) pathway with the specific inhibitor Y27632 completely prevented androgen-induced potentiation. In agreement, androgens elicited ROK-induced Ser19 phosphorylation of myosin light chain 2 in ileal muscle. These data indicate that androgens potentiate ileal contractile activity by an AR-dependent nongenomic mechanism involving intracellular polyamine signaling and Ca2+ sensitization via ROK activation.